Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ...
Regeneron Pharmaceuticals Inc. convinced the First Circuit to impose a higher causation standard in the government’s False Claims Act case alleging a drug kickback scheme, according to a Tuesday ...
The stock's rise snapped a four-day losing streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback